Media Center
Our news
-
05 December 2023
-
31 May 2023
-
20 April 2023
-
02 November 2020
-
07 March 2018
-
07 February 2018
-
26 December 2017
-
22 December 2017
-
11 August 2017
-
30 May 2017
NovaMedica began construction of a pharmaceutical plant in the Kaluga region
Media about us
-
12 February 2018
A new training center will be established in NovaMedica Innotech
GMP News
NovaMedica, a Russian pharmaceutical company and the investment project of RUSNANO, has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company and a leader in the global market of excipients for pharmaceutical industry.
-
02 February 2018
Syndax entered a clinicial trial collaboration with AstraZeneca
GMP News
Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced a new clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca’s durvalumab.
-
02 February 2018
AstraZeneca, Syndax ally to test PD-L1 drug and CSF1R inhibitor in solid tumor patients
Nick Paul Taylor / FierceBiotech
AstraZeneca and Syndax have teamed up to test immune checkpoint inhibitor Imfinzi in combination with CSF1R inhibitor SNDX-6352. Syndax is set to put the cocktail through a phase 1b solid tumor trial to equip both companies to sponsor midphase trials to demonstrate its safety and efficacy.
-
23 January 2018
#WBSMoscow
As the blockchain revolution gains momentum around the world, Trescon had the opportunity to interview Maxim Gorbachev, a Managing Partner at RMI Partners, on the evolving nature of blockchain. RMI Partners is a venture capital company established in 2012, with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies.
Portfolio companies news
-
17 July 2018
Clearside Biomedical, Inc. (“Clearside”), (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that data from PEACHTREE, its pivotal Phase 3 trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis, will be shared as a late-breaking oral presentation during the 2018 annual meeting of the American Society of Retina Specialists , July 20-25 in Vancouver, Canada .
-
11 July 2018
Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
-
10 July 2018
Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer
-
21 June 2018
Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index
-
19 June 2018
Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
-
15 June 2018
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
In the Spotlight
-
The RMI group has completed sertain projects
The RMI group has completed sertain projects
Industry news
-
EMA Relocation Countdown: Some Industry Viewpoints
July 1, 2018 marked the start of the six-month countdown to the European Medicines Agency (EMA) relocation of its operations to Amsterdam. Worryingly, there remains little guidance or clarity from the EMA as to the implications of the move, and Brexit, on the pharma industry.
-
17 July 2018
-
17 July 2018
Could even more cancer patients benefit from PARP inhibitors?
-
16 July 2018
Russian Researchers Create Software that Predicts Parkinson’s Symptoms